Weight Loss Patient Characteristics

A gastric bypass weight loss program is for those who are recuperating from gastric bypass surgery to assist them to heal and alter bad eating habits. Gastric bypass surgery is among several weight-loss surgical procedures presently carried out. The operation itself has gone through several modifications through the years. The process being used today is known as the Roux-en-Y gastric bypass. It should not be mistaken with other weight-loss surgical procedures, like the biliopancreatic diversion with duodenal switch, that is a more aggressive surgery. Your physician or perhaps a registered dietitian will talk to you concerning the diet you will need to follow after surgery, explaining what kinds

Gastric bypass is a surgical procedure that involves removing a large chunk of your stomach and attaching the remainder to your small intestine, making you feel full with less food. I’ve chosen this weight loss surgery as the method for you because of its speedy surgery and easiness. In the article “Reversal of Type 2 Diabetes Mellitus

The diagnosis of a patient for bariatric surgery begins with measurement of the patient's degree of obesity. This measure is important because the NIH and almost all health insurers have set

Gastric bypass surgery as a whole is not a quick fix for reducing one's weight, but is a lifelong struggle with strict adherence to the given diets and exercises every day to the letter. This is the reason why most, if not all, insurance companies have compulsory requirements to safeguard the individual's health and well-being in a long term view. Gastric Bypass is a surgical procession used to assistance a studious remove weight. It is customarily endorsed to assistance those who have been morbidly portly

Soon, in addition to providing care tailored to the obese patient, IR may be called upon to treat obesity directly with left gastric artery (LGA) embolization, which could be a stand-alone treatment, or an adjunctive therapy to bariatric surgery. According to a recent NIH assessment, bariatric surgery is offered to three distinct groups of patients: first, those with BMI ≥40 kg/m2 with no major medical comorbidities, typically after they have failed lifestyle modification; second, patients with BMI ≥35 kg/m2 and a serious medical comorbidity like hypertension, obstructive sleep apnea or type 2 diabetes are also eligible; third, patients with BMI ≥30 kg/m2 and uncontrolled diabetes or metabolic syndrome are candidates for bariatric surgery.

A study that was conducted in Italy which consisted of a group of patients that underwen gastric band surgery and another group that underwent gastric bypass surgery, sought to see the long term effects that each distinvtive surgery had on the pateints, ten years after they ntially underwent it. What they found was that the pauitents in the gastric bypass group, loss a singinantly greater percetage of excess weight (69%) compared to the band pateints who lost 46% of their excess weight over the ten year span. It's also worth noting that they also obsevered that approxiamtely 40% of the band patents, needed more surgery, over the course of ten yeears, in comprarions to the gastric bypass

The number of gastric bypass surgeries has been increased in the last few years and it is considered the ‘‘gold standard’’ of bariatric operations. Bariatric operation or weight reduction surgery is recommended mainly for people whose BMI exceeds 40 kg/m2 as reported by the National Institutes of Health Consensus Development Program, or for those whose BMI is between 35 – 40 40 kg/m2 and who are have life-threatening complications such as cardiac problems (Franco et al., 2011). On the one hand, traditional treatments for weight loss such as lifestyle change do not work for some people. On the other hand, bariatric surgeries have emerged as an effective and safe treatment for obesity; most patients lose 60% of their weight within the first year (Lemmens et al., 2014). Three procedures are commonly performed: laparoscopic Roux-en-Y gastric bypass (LRYGB), the novel laparoscopic sleeve gastrectomy (LSG), and laparoscopic adjustable gastric banding (LAGB). Of these, the Roux-en-Y gastric bypass is the most common (Franco et al., 2011).

One other limitation that should be acknowledged is that many of the randomized controlled trials compared Bariatric surgery to conventional therapy in populations that were mildly to morbidly obese. It was difficult to find trials that compared therapies in patients that had a BMI < 30 kg/m2. Future research needs to study the impact of metabolic surgery on non-obese T2DM patients in order to appreciate the range of application that surgery could have on

Some of them are still under development, but others have already been approved by the FDA in the USA, or are currently used in Europe and South America. Its main assets are its higher safety profile, its greater effectiveness as compared with hypo-caloric diets and modification of habits, and its lower price and greater availability than bariatric surgery. Endoscopic bariatric therapy is gaining acceptance as more effective and less invasive than bariatric surgery. In addition, it can be used as an adjunctive therapy for patients with obesity who are unable to manage the disease with lifestyle interventions alone, or used prior to bariatric surgery.3-5 The goal of primary EBT is to induce weight loss and improvement in medical co-morbidities, with a safety and efficacy profile similar to operative bariatric therapy. Endoscopic bariatric therapy can consist of any of the following procedures: intragastric balloon (IGB) placement, endoscopic sleeve gastroplasty, gastric-bypass revision, and aspiration therapy.3,5. Multiple devices and procedures are currently being evaluated for clinical use or are currently in clinical

Feld et al (2003) randomized thirty obese patients undergoing gastric bypass into two groups: one receiving sevoflurane and fentanyl while the other group received a sevoflurane and non-opioid regimen. The non-opioid regimen

A randomized controlled trial carried out by Ikramuddin et al. (2013) compared conventional standard therapy with lifestyle modification to a single type of Bariatric operation (Roux-en-Y gastric procedure [RYGB]) and measured the effect on glucose control in patients with T2DM. The key outcome and measure of this study with respect to glycemic control was to attain a target HbA1c level below 7% (Ikramuddin et al., 2013). At baseline, these patients had

Long-term weight loss is the desired end-result following gastric bypass surgery. However, this long-term goal is contingent upon lifestyle changes, including nutrition and exercise. More importantly, postoperative gastric bypass patients often have limited knowledge with regard to how to maximize weight loss. In order to measure changes and progress, two critical concepts to achieve optimal weight loss results are body mass index (BMI) and calculation of daily caloric intake. It is imperative to find out the status of respondents in post gastric bypass surgery (P), if ongoing nutrition and lifestyle training (I) compared to standard postoperative guidance (C) result in greater weight loss and decreased BMI (O) over a period of time (T)?

One third of the American adult population is considered to be overweight, a figure that is still on the rise. Numerous studies have presented the negative impacts that obesity has on health and how every organ system in the human body is affected. When minimally invasive strategies such as life style changes fail, bariatric surgery procedures have become the other option. The purpose of this literature review is to look at the outcomes of post-operative pain, post-operative nausea and vomiting, and the length of stay in the post-anesthesia care unit in obese adults undergoing bariatric

When reviewing the literature found during research on the Lewis J. Ort library database, bariatric surgery, when conducted on adolescents and children resulted in “effective early weight loss for morbidly obese adolescents, and that this weight loss results in clear improvements to metabolic as well as psychosocial outcomes” (Stefater, Jenkins, & Inge, 2012). Post bariatric outcomes are also quite similar to those of adults who have the same surgery “with Roux-en-Y gastric bypass producing the greatest weight loss with the most robust evidence base” (Black, White, Viner, & Simmons, 2013). Studies show that the mean weight loss of participants decreased by twenty-seven percent of the total cohort. The benefits continue with the “remission

The second article selected as best evidence was a randomized control trial by (Anita P. Courcoulas, Bret H Goodpaster, Jessie Eagleton, Steven H Belle, Melissa A Kalarchian, Wei Land, and Frederico G.S. Toledo, 2014). The study concluded that bariatric surgery was an effective weight loss measure that resulted in low HbA1c, low glycemic index, decrease in diabetes medication intake and type II diabetes remission. The sample size was small which affecting the study findings generalizability and transferability. In addition, the study included people with broad range of diabetes severity and follow up was limited to 1 year leading to no definitive conclusions drawn. (Courcoulas et al, 2014). Strengths of the study were, it was a comparison of two current and most common surgical procedure with an intensive non-surgical arm that has been reported (Courcoulas et al, 2014). There was consistency findings in comparison to other studies which increased the study’s reliability .There is a further need for randomized control trial in larger population and in different sites to compare the three bariatric surgical procedures with conventional therapy in long term management of type II diabetes. Despite much interest and growing body of literature, there is lack of enough level 1 evidence to support the use of bariatric surgery to treat type II diabetes, bariatric surgery is